A British company has demonstrated the key fuel compression principle underpinning FLARE, its proprietary approach to inertial fusion. First Light Fusion showcased this approach in a series of experiments on M3, the company’s in-house pulsed power facility. FLARE separates the two main steps needed for fusion: first compressing the fuel, then rapidly igniting it. Much like an engine compresses fuel before ignition, FLARE first assembles the fuel to high density before delivering a separate, rapid burst of energy to trigger fusion. The M3 experiments validate the first of these stages: compressing fuel to high density using a simple, lower power driver.

Modern computer chips hold tens of billions of transistors on a piece of silicon a few centimeters across. Making chips faster and more efficient means fitting more transistors onto the same area, shrinking them toward the scale of individual atoms. The problem is that silicon starts to misbehave as it gets thinner. Current leaks through transistors that should be switched off, and electrons move more sluggishly through channels only a few atoms thick.

Researchers have discovered novel antimicrobial peptides derived from Brevibacillus laterosporus DSM 25 that demonstrate significant potential against antibiotic-resistant pathogens. These peptides function by targeting MurT ligase, a bacterial enzyme critical for cell wall synthesis. The study reveals that these antimicrobial peptides exhibit broad-spectrum activity against multiple drug-resistant microorganisms, addressing a growing clinical challenge in treating infections resistant to conventional antibiotics. This finding is particularly important given the rising prevalence of multidrug-resistant bacteria worldwide, which threatens treatment efficacy and patient outcomes. By targeting a specific enzymatic mechanism essential for bacterial survival, these peptides offer a novel therapeutic approach that could potentially circumvent existing resistance mechanisms. The development of antimicrobial peptides from natural bacterial sources represents a promising strategy for discovering new antimicrobial agents. This research contributes to the expanding arsenal of alternative treatments needed to combat the global antimicrobial resistance crisis and may facilitate development of next-generation therapeutics.

Shape memory polymers enable 4D printing—additive manufacturing where time serves as the fourth dimension, allowing printed parts to change shape on demand. Unlike traditional 3D printing, 4D-printed components are produced in their permanent designed state, then deformed and held in temporary configurations until reactivated. The polymer chains lock into place while cooled and return to their original geometry when triggered. Activation mechanisms vary by chemistry and application, including heat, moisture, light, or magnetic fields, with different printing techniques—fused deposition modeling, stereolithography, and selective laser sintering—accommodating diverse polymer formulations. This programmable shape-shifting capability enables transformative applications across multiple industries. One prominent example involves vascular stents designed with negative Poisson's ratio structures optimized through genetic algorithms. These stents compress for delivery through narrow blood vessels, then expand upon reaching body temperature to restore proper blood flow. The ability to customize both material properties and activation triggers during design makes 4D printing valuable for aerospace, medical devices, soft robotics, and deployable structures where space constraints or functionality demands require shape transformation after initial placement.

Chronic wounds and pathological scarring present significant regenerative medicine challenges due to dysregulated tissue repair processes. A comprehensive review by researchers at Zhejiang University proposes an innovative phase-oriented framework for developing bio-inks specifically designed for skin regeneration through 3D bioprinting technology. The study establishes critical connections between bio-ink properties and the dynamic biological requirements of distinct wound-healing stages, integrating material engineering with regenerative mechanisms. A major finding identifies a substantial gap: current phase-specific bio-ink design remains underdeveloped and largely implicit in existing healing phase analyses. The research highlights emerging 4D bioprinting strategies and advocates for adaptive bio-inks guided by multi-omics datasets to create stage-responsive systems capable of modulating therapeutic delivery according to evolving wound repair requirements. These advancements could substantially improve chronic wound treatment outcomes and minimize pathological scarring, offering considerable potential for advancing regenerative medicine applications and restoring functional tissue architecture.

Soft robots represent a transformative advancement in robotics, offering superior compliance, safety, and environmental adaptability compared to conventional rigid systems. These robots, inspired by biological structures like elephant trunks and octopus tentacles, excel in healthcare, intelligent manufacturing, and human-machine interaction applications. This comprehensive review examines the critical technologies enabling soft robot functionality: actuation strategies that determine motion generation and response capability, and flexible sensing technologies that enable perception and feedback control. The review emphasizes the integration of actuation and sensing systems, discussing proprioception, exteroception, and multimodal information fusion approaches essential for precise control and intelligent environmental interaction. By synthesizing recent advances in these coupled systems, the review addresses current technical challenges while outlining future perspectives for next-generation intelligent soft robotics. With artificial intelligence and advanced sensing technologies advancing rapidly, embodied intelligence has emerged as a promising paradigm enabling robots to perceive, adapt, and interact effectively with complex, unstructured environments. These developments expand soft robotics' applications and establish them as increasingly important in future intelligent societies.

A comprehensive empirical study examining 86 countries—40 developed and 46 developing—from 2010 to 2024 reveals critical insights into how green finance and technological innovation drive sustainable growth. Using advanced econometric techniques including pooled ordinary least squares regression, fixed effects models, random effects models, and generalized method of moments estimation to account for endogeneity, researchers found that technological innovation consistently contributes positively to sustainable growth, particularly in developing nations. However, green finance demonstrates counterintuitive short-term negative effects on sustainable growth, suggesting implementation challenges during transition periods. Institutional quality emerges as a crucial moderating factor that significantly enhances the effectiveness of both green finance and technological innovation. These findings underscore that countries must prioritize strengthening institutional frameworks and improving resource allocation efficiency alongside supporting technological advancement to fully realize green finance benefits during the transition toward sustainable economic growth.

Nanomedicine has emerged as a transformative approach to cancer diagnosis and therapy by leveraging nanotechnology to overcome limitations of conventional treatments. Researchers from Assam University present a comprehensive review examining how tuning nanoparticle properties—including size, morphology, and surface charge—enables controlled targeted drug delivery, improved cellular uptake, and therapeutic release. The review systematically discusses advances across polymeric, lipid-based, inorganic, biological, and hybrid nanocarriers, emphasizing surface engineering, ligand-mediated targeting, and multifunctional delivery systems. These platforms address critical challenges including poor aqueous solubility, unfavorable pharmacokinetics, systemic toxicity, and drug resistance associated with traditional therapies. However, significant hurdles persist regarding tumor-specific accumulation, intratumoral heterogeneity, and long-term outcomes. The authors address major translational obstacles including large-scale fabrication, reproducibility, safety concerns, and regulatory barriers. Emerging strategies highlighted include personalized nanomedicine, combination therapies, and artificial intelligence-assisted nanoparticle design, positioning next-generation nanomedicine as essential to advancing safer, more effective, and patient-centered cancer treatment approaches.

Four-dimensional printing represents an evolution of traditional 3D printing where the "fourth dimension" refers to time-dependent shape transformation. Unlike conventional 3D printing, which produces static objects through layer-by-layer material deposition, 4D printing creates structures capable of changing shape, function, or properties over time when exposed to specific environmental stimuli such as heat, moisture, or light. This capability is enabled by smart materials, shape-memory polymers, and programmable structures that have advanced significantly in recent years. A 4D-printed object might transform from a flat strip into a ring when exposed to hot water, for instance, either permanently or reversibly depending on material properties. While 4D printing has been under research for years, recent breakthroughs in smart materials engineering have elevated it into a serious industrial field. The technology holds potential implications for consumer applications and home use, though practical adoption for desktop 3D printers remains in development stages as researchers refine materials and printing techniques to make the technology more accessible and functional for widespread implementation.

Nanotechnology is revolutionizing precision medicine through advanced smart biomaterials, including engineered extracellular vesicles, stimuli-responsive hydrogels, and intelligent implant materials that address limitations of conventional therapies such as poor targeting and systemic toxicity. However, translation of these innovative platforms from laboratory success to clinical deployment is frequently hindered not by insufficient efficacy, but rather by inadequate characterization of biological interactions and safety profiles. Current toxicity, immunogenicity, and biocompatibility assessments often lack rigor and fail to account for critical variables including sex, age, and exposure route that significantly influence biological outcomes. This Research Topic seeks multidisciplinary contributions that maintain smart biomaterials for targeted delivery and regenerative medicine as central focus while mandating comprehensive biological safety evaluation alongside material design. The initiative aims to showcase innovative platforms with complete structure–property–function and biocompatibility data necessary to evaluate translational readiness, from nanoscale delivery systems to functional biomedical materials. Contributions addressing Sustainable Development Goals three, nine, and twelve are particularly welcomed, encompassing biocompatibility evaluation, nanozymes design, and functional hydrogels while excluding clinical trials, drug discovery, and bibliometric analyses.

For years, recursive self-improvement, or RSI, was mostly something we talked about as a future threshold. The concept is that AI helps create a better AI; that better AI becomes better at improving AI, and eventually you have a feedback loop where the machine starts contributing materially to the creation of its own successors. Altough we are not at the final version of that loop yet, but over the last 18 months, something important has changed. AI systems have begun improving the persistent parts of the machinery they use to solve problems.

# Summary Researchers have developed NIR-II (near-infrared region II) conjugated polymers as innovative therapeutic agents for tumor sonodynamic therapy. This approach represents a significant advancement in cancer treatment by combining two emerging technologies: near-infrared photoacoustic imaging and ultrasound-activated therapy. NIR-II conjugated polymers possess unique optical and acoustic properties that enable them to accumulate in tumor tissues and generate reactive oxygen species when exposed to ultrasound, effectively destroying cancer cells while minimizing damage to healthy surrounding tissue. The polymers' extended near-infrared absorption allows for deeper tissue penetration compared to traditional visible-light therapies, improving treatment efficacy. This research matters because sonodynamic therapy offers a non-invasive alternative to conventional cancer treatments with potentially fewer side effects. The development of these specialized polymers enhances treatment precision and therapeutic outcomes, opening new possibilities for personalized cancer care and potentially addressing limitations of existing chemotherapy and radiation approaches in oncology.

Three-dimensional bioprinting represents a transformative approach to treating musculoskeletal injuries affecting tendons and ligaments, which currently present significant clinical challenges due to slow healing rates and complex multilayered tissue architecture. Traditional repair methods such as autografts and allografts suffer from donor site morbidity, limited availability, and potential immunological rejection. The emerging 3D bioprinting technology enables the creation of patient-specific grafts that accurately replicate the anatomical and physiological characteristics of injured sites. Researchers are developing advanced bioinks combining decellularized extracellular matrix (dECM) and synthetic polymers to engineer constructs that promote regenerative rather than merely reparative healing. However, significant challenges remain, including replicating the mechanical anisotropy of natural tissues, ensuring seamless integration at the tendon-bone interface (enthesis), and navigating complex regulatory pathways toward clinical implementation. Given that approximately 200,000 anterior cruciate ligament (ACL) injuries occur annually in the United States alone, developing effective repair strategies is critical. This comprehensive review examines bioink development, multiscale scaffold design, biomechanical considerations, and translational challenges while providing a roadmap for advancing laboratory prototypes into clinically viable next-generation implants that will enhance musculoskeletal care standards.

The proliferation of AI-powered surveillance cameras has sparked significant public concern over facial recognition, license plate readers, and data privacy. In response, a creative resistance movement is emerging through adversarial fashion and technological countermeasures. Cybersecurity expert Bill Swearingen developed a Python-based fuzzer in 2025 that targets YOLO, a popular object detection framework, generating adversarial patterns tested against eleven different computer vision models. These colorful geometric designs successfully reduce detection confidence scores across facial recognition, face recognition, and people detection systems. Companies like Cap_able and Urban Privacy are commercializing this technology, producing garments with patented jacquard-knit patterns that interfere with convolutional neural networks, potentially causing systems to misclassify wearers as animals or objects. Cap_able founder Rachele Didero emphasizes using these visible, tangible items to address the intangible threat of surveillance. Additionally, the DeFlock project maps automated license plate readers while others present alternatives like the noRecognition initiative at DEF CON. These efforts reflect growing recognition that privacy constitutes a fundamental human right requiring active protection against increasingly invasive surveillance infrastructure.

Four-dimensional printing represents an emerging frontier in additive manufacturing by integrating smart materials with traditional 3D printing technologies to create structures that can dynamically transform over time in response to environmental stimuli. This review, published in August 2026 in the Bulletin of Materials Science, examines the convergence of smart materials, advanced manufacturing processes, and industrial applications driving this innovation. The article synthesizes current research on stimulus-responsive polymers, shape-memory alloys, and hydrogels used in 4D printing, alongside manufacturing techniques enabling precise material deposition and programmable geometry changes. Key applications span aerospace, biomedics, and consumer electronics, where adaptive structures offer significant advantages. The significance of 4D printing lies in its potential to revolutionize product design by enabling self-assembly, autonomous repair, and environmental responsiveness without mechanical actuation. This technology promises substantial cost reductions in manufacturing complex adaptive systems while addressing sustainability concerns through reduced waste and extended product lifecycles, positioning it as a transformative force in next-generation manufacturing.

Three-dimensional bioprinting has emerged as a transformative technology in tissue engineering and regenerative medicine, with significant advances in recent years. This comprehensive review examines the critical interface between bioprinting deposition mechanisms—including inkjet, laser-assisted, vat-polymerization, and extrusion-based systems—and bioink chemistry. The analysis reveals fundamental trade-offs inherent to the field: resolution versus construct size, printability versus biological functionality, and scalability versus cell viability. Natural, synthetic, and hybrid bioinks are evaluated for their physicochemical properties and capacity to direct cell fate in neural, vascular, and musculoskeletal applications. Key translational barriers are identified, including immunogenicity, foreign body responses, batch-to-batch variability, and the absence of standardized Good Manufacturing Practice–compliant workflows. To advance clinical translation, the review prioritizes stimuli-responsive bioinks, real-time monitoring integration, artificial intelligence–assisted design optimization, and multi-material bioprinting capabilities. These developments are essential for transforming laboratory innovations into reproducible, clinically viable tissue constructs suitable for therapeutic applications.

Microbial contamination and antimicrobial resistance pose escalating threats to global health, food safety, and clinical settings. Researchers at Monash University have conducted a comprehensive review examining antimicrobial materials designed to combat resistant microorganisms. The study focuses on antimicrobial peptides (AMPs), which function as the immune system's first defense by binding to and disrupting bacterial cell membranes. The researchers explored polymer-based antimicrobial materials that either mimic the cationic properties of AMPs or have AMPs grafted onto polymer templates, with these materials operating through membrane disruption mechanisms. Given that antibiotic resistance is increasing at alarming rates and at least nineteen alternative agents are currently in development pipelines, antimicrobial materials represent a promising avenue for managing contamination in healthcare, agricultural, and veterinary environments. This review synthesizes existing knowledge on molecular mechanisms of action, providing a timely assessment of how these innovative materials can effectively address the growing challenge of multi-drug resistant bacterial infections and support global health security.

The development of 4D materials has expanded adaptive manufacturing; however, most systems are limited to passive shape changes and lack interactive sensory functions. Here, we present an olfactory-responsive 4D material with integrated antimicrobial activity. The material exhibits shape-memory behaviour under external stimuli and releases aromatic compounds upon heating, enabling multisensory interaction. A photocurable resin was formulated using carvone, a naturally derived monoterpene from spearmint, as a nonreactive diluent, together with diurethane dimethacrylate (DUDMA) and phenylbis(2,4,6-trimethylbenzoyl)phosphine oxide (BAPO). Containing up to 25% renewable content, the formulation provides a sustainable alternative to conventional petroleum-based systems.

Business crowdfunding enables entrepreneurs to raise capital from numerous individual backers through online platforms, with each contributor providing modest amounts during time-limited campaigns. This approach offers an alternative to traditional financing, venture capital, and angel investors, allowing founders to retain greater control. The modern crowdfunding landscape emerged with Kickstarter and Indiegogo launching in 2008-2009, pioneering rewards-based models where backers receive perks like early product access. The 2012 JOBS Act legalized equity-based crowdfunding, enabling businesses to sell ownership stakes to everyday investors, with the SEC's Regulation Crowdfunding framework taking effect in 2016. Campaigns typically run 30 to 60 days and involve four funding models: rewards-based, equity-based, donation-based, and debt-based financing. Platforms employ either all-or-nothing or flexible funding structures, with typical fees comprising approximately five percent platform fees and three percent payment processing charges. Understanding these mechanisms and associated costs is essential for business owners evaluating crowdfunding as a capital-raising strategy in the evolving 2026 marketplace.

Exosomes and liposomes represent two distinct approaches to drug delivery, each occupying different positions in therapeutic development. While structurally similar—both spherical, lipid bilayer-enclosed nanoparticles carrying aqueous payloads—they differ fundamentally in their nature. Liposomes are a fifty-year-old, clinically approved technology assembled from defined components like hydrogenated soy phosphatidylcholine, cholesterol, and PEGylated lipids, offering complete compositional control and reproducibility. Exosomes, conversely, are naturally secreted extracellular vesicles produced through endosomal budding, inheriting their composition from parent cell biology with enriched cholesterol, sphingomyelin, phosphatidylserine, and surface proteins like tetraspanins. The critical distinction lies in their design philosophy: liposomes are engineered systems requiring deliberate addition of desirable properties, while exosomes are biomimetic platforms arriving with inherent biological characteristics. Selecting between them depends on specific therapeutic requirements across multiple criteria including cargo loading, targeting capabilities, immune handling, manufacturability, analytical control, and regulatory precedent, rather than determining which is intrinsically superior.